Why the study?
Severe tricuspid regurgitation carries an increased risk of morbidity, hospitalization, and mortality, leaving patients at high surgical risk with limited therapeutic options.
Does T-TEER improve outcomes in patients with severe, symptomatic tricuspid regurgitation at high surgical risk?
Population
Patients with severe, symptomatic TR at high surgical risk
Comparison
T-TEER
Design
Review
Key result
Transcatheter tricuspid edge-to-edge repair (T-TEER) reduces tricuspid regurgitation to moderate or less in approximately 81-88% of patients, improving functional status and quality of life.
Authors
Loading...
May support T-TEER consideration in high-risk severe TR; leaves open confirmation by randomized trials.
Does T-TEER improve outcomes in patients with severe, symptomatic tricuspid regurgitation at high surgical risk?
T-TEER represents a safe and effective minimally invasive treatment option for patients with severe, symptomatic tricuspid regurgitation at high surgical risk.
Berliner et al. (2026) conducted a review in Severe tricuspid regurgitation. Transcatheter tricuspid edge-to-edge repair (T-TEER) was evaluated on Reduction of tricuspid regurgitation to moderate or less. Transcatheter tricuspid edge-to-edge repair (T-TEER) reduces tricuspid regurgitation to moderate or less in approximately 81-88% of patients, improving functional status and quality of life.